Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company.
A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cabaletta Bio Inc | Steven Nichtberger | Director, President & CEO | Purchase of securities on an exchange or from another person at price $ 2.24 per share. | 21 Jan 2026 | 45,000 | 1,031,483 (4%) | 0% | 2.2 | 100,778 | Common Stock |
| CVB Fin Corp | David Brager | President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 40,240 | 246,607 (0%) | 0% | 0 | Common Stock | |
| GoodRx Holdings Inc (Class A) | Scott W. Wagner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2026 | 31,394 | 216,663 | - | - | Class A Common Stock | |
| GoodRx Holdings Inc (Class A) | Scott W. Wagner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jan 2026 | 31,394 | 62,788 | - | - | Deferred Stock Unit | |
| Art`s-way Manufacturing Co. Inc | Marc H. Mcconnell | Director, President, CEO and Chairman, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 30,000 | 251,500 (5%) | 0% | 0 | Common Stock | |
| Drilling Tools Intl Corp | Michael W. Domino | President, DTR Division | Sale of securities on an exchange or to another person at price $ 4.00 per share. | 21 Jan 2026 | 24,996 | 1,433,054 | - | 4 | 99,984 | Common Stock |
| Cabaletta Bio Inc | Shawn Cline Tomasello | Director | Purchase of securities on an exchange or from another person at price $ 2.21 per share. | 21 Jan 2026 | 22,725 | 22,725 (0%) | 0% | 2.2 | 50,322 | Common Stock |
| Cabaletta Bio Inc | Steve Gavel | Chief Commercial Officer | Purchase of securities on an exchange or from another person at price $ 2.26 per share. | 21 Jan 2026 | 22,170 | 22,170 (0%) | 0% | 2.3 | 50,215 | Common Stock |
| Art`s-way Manufacturing Co. Inc | Michael W. Woods | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 15,000 | 41,999 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Mark J. Alvino | Director | Sale of securities on an exchange or to another person at price $ 5.23 per share. | 21 Jan 2026 | 13,500 | 48,752 (0%) | 0% | 5.2 | 70,574 | Common Stock |
| CVB Fin Corp | Harvey C David | EVP Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 13,365 | 137,977 (0%) | 0% | 0 | Common Stock | |
| CVB Fin Corp | E. Allen Nicholson | EVP & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 13,365 | 127,576 (0%) | 0% | 0 | Common Stock | |
| Gamestop Corp (Class A) | Alain Attal | Director | Purchase of securities on an exchange or from another person at price $ 21.63 per share. | 21 Jan 2026 | 12,000 | 596,464 (0%) | 0% | 21.6 | 259,577 | Class A Common Stock |
| Cabaletta Bio Inc | Gwendolyn K. Binder | President, Science & Tech. | Purchase of securities on an exchange or from another person at price $ 2.19 per share. | 21 Jan 2026 | 11,312 | 31,312 (0%) | 0% | 2.2 | 24,763 | Common Stock |
| Outfront Media Inc | Manuel A. Diaz Rodriguez | Director | Sale of securities on an exchange or to another person at price $ 24.49 per share. | 21 Jan 2026 | 11,271 | 47,515 (0%) | 0% | 24.5 | 276,027 | Common Stock |
| CVB Fin Corp | David F. Farnsworth | EVP & CCO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 10,288 | 81,538 (0%) | 0% | 0 | Common Stock | |
| Marriott Vacations Worldwide Corp | Jason P. Marino | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 10,000 | 34,711 (0%) | 0% | 0 | Common Stock | |
| Marriott Vacations Worldwide Corp | John D. Fitzgerald | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 10,000 | 26,379 (0%) | 0% | 0 | Common Stock | |
| CVB Fin Corp | Yamynn DeAngelis | EVP Chief Risk Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 10,000 | 138,026 (0%) | 0% | 0 | Common Stock | |
| RenovoRx Inc | Ramtin Agah | Director, Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 1.00 per share. | 21 Jan 2026 | 10,000 | 798,460 | - | 1.0 | 9,975 | Common Stock |
| CVB Fin Corp | Richard H. Wohl | EVP & General Counsel | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 9,014 | 50,169 (0%) | 0% | 0 | Common Stock | |
| Cabaletta Bio Inc | David J. Chang | Chief Medical Officer | Purchase of securities on an exchange or from another person at price $ 2.26 per share. | 21 Jan 2026 | 8,800 | 8,800 (0%) | 0% | 2.3 | 19,888 | Common Stock |
| D.R. Horton | Michael J. Murray | EVP and COO | Gift of securities by or to the insider at price $ 0.00 per share. | 21 Jan 2026 | 7,060 | 122,615 (0%) | 0% | 0 | Common Stock | |
| Cabaletta Bio Inc | Michael Gerard | General Counsel | Purchase of securities on an exchange or from another person at price $ 2.27 per share. | 21 Jan 2026 | 6,600 | 6,600 (0%) | 0% | 2.3 | 14,979 | Common Stock |
| Cabaletta Bio Inc | Catherine Bollard | Director | Purchase of securities on an exchange or from another person at price $ 2.27 per share. | 21 Jan 2026 | 4,405 | 5,405 (0%) | 0% | 2.3 | 9,982 | Common Stock |
| CVB Fin Corp | Sheryl P. Laygo | Chief Accounting Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Jan 2026 | 3,500 | 15,144 (0%) | 0% | 0 | Common Stock | |
| Progressive | Jonathan S. Bauer | Chief Investment Officer | Sale of securities on an exchange or to another person at price $ 204.35 per share. | 21 Jan 2026 | 3,105 | 26,248 (0%) | 0% | 204.4 | 634,507 | Common |
| Universal Technical Institute Inc | Carolyn Ann Frank | SVP/Chief HR Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 27.49 per share. | 21 Jan 2026 | 2,162 | 32,022 (0%) | 0% | 27.5 | 59,433 | Common Stock, $0.0001 par value |
| Progressive | Andrew J. Quigg | Chief Strategy Officer | Sale of securities on an exchange or to another person at price $ 204.35 per share. | 21 Jan 2026 | 1,649 | 39,626 (0%) | 0% | 204.3 | 336,973 | Common |
| Innovative Eyewear Inc | Harrison R. Gross | Director, Chief Executive Officer | Purchase of securities on an exchange or from another person at price $ 1.32 per share. | 21 Jan 2026 | 1,500 | 13,733 | - | 1.3 | 1,980 | Common Stock |
| IPG Photonics Corp | Eugene A. Scherbakov | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 81.57 per share. | 21 Jan 2026 | 1,403 | 59,330 (0%) | 0% | 81.6 | 114,443 | Common Stock |
| IPG Photonics Corp | Eugene A. Scherbakov | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 80.37 per share. | 21 Jan 2026 | 1,204 | 60,733 (0%) | 0% | 80.4 | 96,765 | Common Stock |
| Prosperity Bancshares Inc | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 74.30 per share. | 21 Jan 2026 | 499 | 101,193 (0%) | 0% | 74.3 | 37,077 | Common Stock |
| Prosperity Bancshares Inc | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 74.29 per share. | 21 Jan 2026 | 499 | 83,915 (0%) | 0% | 74.3 | 37,070 | Common Stock |
| Erie Indemnity (Class A) | J. Ralph Borneman | Director | Other type of transaction at price $ 0.00 per share. | 21 Jan 2026 | 105 | 20,224 | - | - | Directors Deferred Compensation Share Credits | |
| Erie Indemnity (Class A) | C. Scott Hartz | Director | Other type of transaction at price $ 0.00 per share. | 21 Jan 2026 | 99 | 19,119 | - | - | Directors Deferred Compensation Share Credits | |
| Prosperity Bancshares Inc | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 74.33 per share. | 21 Jan 2026 | 95 | 42,200 (0%) | 0% | 74.3 | 7,061 | Common Stock |
| IPG Photonics Corp | Eugene A. Scherbakov | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 79.33 per share. | 21 Jan 2026 | 93 | 61,937 (0%) | 0% | 79.3 | 7,378 | Common Stock |
| Erie Indemnity (Class A) | Jonathan Hirt Hagen | Director | Other type of transaction at price $ 0.00 per share. | 21 Jan 2026 | 87 | 16,817 | - | - | Directors Deferred Compensation Share Credits | |
| Erie Indemnity (Class A) | Thomas B. Hagen | Director | Other type of transaction at price $ 0.00 per share. | 21 Jan 2026 | 74 | 14,299 | - | - | Directors Deferred Compensation Share Credits | |
| Erie Indemnity (Class A) | LuAnn Datesh | Director | Other type of transaction at price $ 0.00 per share. | 21 Jan 2026 | 21 | 4,058 | - | - | Directors Deferred Compensation Share Credits | |
| Erie Indemnity (Class A) | Eugene C. Connell | Director | Other type of transaction at price $ 0.00 per share. | 21 Jan 2026 | 17 | 3,266 | - | - | Directors Deferred Compensation Share Credits | |
| Erie Indemnity (Class A) | Salvatore Correnti | Director | Other type of transaction at price $ 0.00 per share. | 21 Jan 2026 | 14 | 2,686 | - | - | Directors Deferred Compensation Share Credits | |
| Prosperity Bancshares Inc | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 72.40 per share. | 21 Jan 2026 | 5 | 42,295 (0%) | 0% | 72.4 | 362 | Common Stock |
| Prosperity Bancshares Inc | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 73.00 per share. | 21 Jan 2026 | 1 | 84,414 (0%) | 0% | 73 | 73 | Common Stock |
| Prosperity Bancshares Inc | Ned S. Holmes | Director | Sale of securities on an exchange or to another person at price $ 73.00 per share. | 21 Jan 2026 | 1 | 101,692 (0%) | 0% | 73 | 73 | Common Stock |
| Acadia Healthcare Co Inc | Debra K. Osteen | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 1,125,000 | 1,125,000 | - | - | Stock Option (Right to Buy) | |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 950,000 | 950,000 | - | - | Stock Options (right to buy) | |
| Acumen Pharma Inc | Daniel O'Connell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 450,000 | 450,000 | - | - | Employee Stock Option (right to buy) | |
| Abeona Therapeutics Inc | Vishwas Seshadri | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 365,422 | 1,530,240 (1%) | 0% | 0 | Common Stock | |
| Cosmos Health Inc | Grigorios Siokas | Director, Chief Executive Officer, Ten Percent Owner | Purchase of securities on an exchange or from another person at price $ 0.50 per share. | 20 Jan 2026 | 353,321 | 8,091,795 | - | 0.5 | 175,000 | Common Stock, par value $.001 |
| Atossa Therapeutics Inc | Steven C. Quay | Director, President & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 325,203 | 339,101 (3%) | 3% | 0 | Common Stock | |
| Acumen Pharma Inc | Daniel O'Connell | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 299,800 | 893,310 | - | 0 | Common Stock | |
| Chimera Investment Corp | Phillip J. Kardis | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 194,774 | 695,495 (0%) | 0% | 0 | Common Stock | |
| Citigroup | Viswas Raghavan | Head of Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 135,838 | 569,048 (0%) | 0% | 118.0 | 16,034,352 | Common Stock |
| Abeona Therapeutics Inc | Joseph W. Vazzano | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 133,595 | 587,226 (0%) | 0% | 0 | Common Stock | |
| Abeona Therapeutics Inc | Brendan M. O'Malley | SVP, Chief Legal Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 113,949 | 464,712 (0%) | 0% | 0 | Common Stock | |
| JPMC | James S. Dimon | Director, Chairman & CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 90,000 | 1,667,862 (0%) | 0% | 0 | Common Stock | |
| Essential Properties Realty Trust Inc | Peter M. Mavoides | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.04 per share. | 20 Jan 2026 | 89,139 | 332,754 (0%) | 0% | 30.0 | 2,677,736 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 6.54 per share. | 20 Jan 2026 | 76,967 | 3,166,604 | - | 6.5 | 503,364 | Common Stock |
| ImmunityBio Inc | Barry J. Simon | Director | Sale of securities on an exchange or to another person at price $ 7.88 per share. | 20 Jan 2026 | 75,000 | 3,091,604 | - | 7.9 | 590,933 | Common Stock |
| Citigroup | Jane Nind Fraser | Director, Chair & CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 67,967 | 818,055 (0%) | 0% | 118.0 | 8,022,932 | Common Stock |
| Innovative Industrial Properties Inc | Alan D. Gold | Director, EXECUTIVE CHAIRMAN | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 66,702 | 66,702 | - | - | Restricted Stock Units 2026 | |
| Citigroup | Jane Nind Fraser | Director, Chair & CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 55,000 | 1,055,000 | - | - | Employee Stock Options (Right to Buy) | |
| Chimera Investment Corp | Subramaniam Viswanathan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 54,537 | 247,826 (0%) | 0% | 0 | Common Stock | |
| Dave & Buster`s Entertainment Inc | Kevin M. Sheehan | Director | Gift of securities by or to the insider at price $ 0.00 per share. | 20 Jan 2026 | 50,000 | 39,645 (0%) | 0% | 0 | Common Stock | |
| Innovative Industrial Properties Inc | Paul E. Smithers | Director, PRESIDENT, CEO AND DIRECTOR | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 47,643 | 150,577 (0%) | 0% | - | Common Stock | |
| PPL | Vincent Sorgi | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 45,395 | 0 | - | - | Stock Unit (SIP) | |
| PPL | Vincent Sorgi | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.91 per share. | 20 Jan 2026 | 45,395 | 494,838 (0%) | 0% | 36.9 | 1,675,546 | Common Stock |
| Alx Oncology Holdings Inc | Corey S. Goodman | Director, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 40,400 | 40,400 | - | - | Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Chris H. Takimoto | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 40,400 | 40,400 | - | - | Stock option (right to buy) | |
| Alx Oncology Holdings Inc | Rekha Hemrajani | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 40,400 | 40,400 | - | - | Stock option (right to buy) | |
| Minerals Tech Inc | Douglas T. Dietrich | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 39,000 | 102,253 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Protagonist Therapeutics Inc | Dinesh V. Patel | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 82.48 per share. | 20 Jan 2026 | 34,438 | 580,505 (2%) | 0% | 82.5 | 2,840,446 | Common Stock |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.11 per share. | 20 Jan 2026 | 33,838 | 658,807 (0%) | 0% | 46.1 | 1,560,131 | Common Stock |
| Citigroup | Nicole Giles | CHIEF ACCOUNTING OFFICER | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 33,835 | 97,347 (0%) | 0% | 118.0 | 3,993,966 | Common Stock |
| Minerals Tech Inc | Douglas T. Dietrich | Director, CHAIRMAN AND CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 33,494 | 33,494 | - | - | Employee Stock Option (Right to Buy) | |
| Pinterest Inc (Class A) | William J. Ready | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 25.39 per share. | 20 Jan 2026 | 32,382 | 1,302,493 (0%) | 0% | 25.4 | 822,179 | Class A Common Stock |
| MBX Biosciences Inc | Laurie D. Stelzer | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 32,000 | 32,000 | - | - | Stock option (right to buy) | |
| Chimera Investment Corp | Miyun Sung | Chief Legal Officer & Secy. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 31,164 | 67,958 (0%) | 0% | 0 | Common Stock | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 27,200 | 163,200 | - | - | Employee Stock Option (right to buy) | |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.18 per share. | 20 Jan 2026 | 27,200 | 692,645 (0%) | 0% | 23.2 | 630,496 | Common Stock |
| Citigroup | Anand Selvakesari | Chief Operating Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 27,154 | 202,025 (0%) | 0% | 118.0 | 3,205,315 | Common Stock |
| Progressive | Susan Patricia Griffith | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 23,909 | 24,603 | - | - | Restricted Stock Unit | |
| Progressive | Susan Patricia Griffith | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 23,909 | 495,195 (0%) | 0% | 0 | Common | |
| Neogenomics Inc | Warren C. Stone | Pres & Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 12.50 per share. | 20 Jan 2026 | 22,128 | 121,631 (0%) | 0% | 12.5 | 276,682 | Common Stock |
| Citigroup | Zdenek Turek | Chief Risk Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 21,469 | 206,418 (0%) | 0% | 118.0 | 2,534,262 | Common Stock |
| Central Garden & Pet Co. | George Yuhas | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.80 per share. | 20 Jan 2026 | 20,833 | 26,728 (0%) | 0% | 22.8 | 474,992 | Class A Common Stock |
| Central Garden & Pet Co. | George Yuhas | General Counsel | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 20,833 | 0 | - | - | Stock Option (Right to Buy) | |
| Innovative Industrial Properties Inc | David Smith | CFO AND TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 20,061 | 23,582 (0%) | 0% | - | Common Stock | |
| Fastly Inc (Class A) | Artur Bergman | Director, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 8.18 per share. | 20 Jan 2026 | 20,000 | 2,650,579 (3%) | 0% | 8.2 | 163,600 | Class A Common Stock |
| Citigroup | Syed Shahmir Khaliq | Head of Services | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 19,671 | 84,656 (0%) | 0% | 118.0 | 2,322,045 | Common Stock |
| Central Garden & Pet Co. | George Yuhas | General Counsel | Payment of exercise price or tax liability using portion of securities received from the company at price $ 29.01 per share. | 20 Jan 2026 | 18,545 | 8,183 (0%) | 0% | 29.0 | 537,990 | Class A Common Stock |
| Citigroup | Brent McIntosh | Chief Legal Off. & Corp. Secy | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 18,145 | 95,693 (0%) | 0% | 118.0 | 2,141,871 | Common Stock |
| Neuphoria Therapeutics Inc | Alan Fisher | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 17,073 | 30,731 | - | - | Restricted Stock Units | |
| Aura Biosciences Inc | Elisabet de los Pinos | Director, See Remarks | Sale of securities on an exchange or to another person at price $ 4.86 per share. | 20 Jan 2026 | 16,928 | 457,463 | - | 4.9 | 82,270 | Common Stock |
| Republic Bancorp Inc KY | Logan M. Pichel | Director, PRESIDENT & CEO, REPUBLIC BANK | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 16,903 | 16,903 | - | - | Employee Stock Option (right to buy) | |
| Alx Oncology Holdings Inc | Daniel Curran | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 16,833 | 16,833 | - | - | Stock Option (right to buy) | |
| Citigroup | Ernesto Torres Cantu | Head of International | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 16,647 | 148,121 (0%) | 0% | 118.0 | 1,965,118 | Common Stock |
| Citigroup | Gonzalo Luchetti | Head of U.S. Personal Banking | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 16,492 | 74,611 (0%) | 0% | 118.0 | 1,946,752 | Common Stock |
| Citigroup | Edward Skyler | Hd of Ent Svc & Public Affairs | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 16,415 | 188,311 (0%) | 0% | 118.0 | 1,937,656 | Common Stock |
| PPL | Vincent Sorgi | President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 36.91 per share. | 20 Jan 2026 | 16,001 | 478,837 (0%) | 0% | 36.9 | 590,597 | Common Stock |
| Citigroup | Sara Wechter | Chief Human Resources Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 15,490 | 92,414 (0%) | 0% | 118.0 | 1,828,520 | Common Stock |
| Citigroup | Sunil Garg | CEO, Citibank, N.A. | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 15,199 | 124,797 (0%) | 0% | 118.0 | 1,794,193 | Common Stock |
| Citigroup | Pamela Habner | Head of U.S. Consumer Cards | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 14,699 | 73,494 (0%) | 0% | 118.0 | 1,735,177 | Common Stock |
| EverQuote Inc (Class A) | Jayme Mendal | Director, CEO and President | Sale of securities on an exchange or to another person at price $ 24.15 per share. | 20 Jan 2026 | 14,360 | 406,404 (3%) | 0% | 24.2 | 346,794 | Class A Common Stock |
| PPL | Joseph P. Bergstein | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.91 per share. | 20 Jan 2026 | 13,938 | 166,009 (0%) | 0% | 36.9 | 514,484 | Common Stock |
| PPL | Joseph P. Bergstein | EVP and CFO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 13,938 | 0 | - | - | Stock Unit (SIP) | |
| First Internet Bancorp | David B. Becker | Director, Chairman and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 12,566 | 432,810 (4%) | 0% | 0 | Common Stock | |
| Penguin Soln Inc | Mark W. Adams | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 19.96 per share. | 20 Jan 2026 | 12,513 | 963,183 (4%) | 0% | 20.0 | 249,759 | Common Stock |
| Minerals Tech Inc | D. J. Monagle | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 12,504 | 34,088 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Citigroup | Titilope Cole | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.04 per share. | 20 Jan 2026 | 12,136 | 60,111 (0%) | 0% | 118.0 | 1,432,548 | Common Stock |
| Nicolet Bankshares Inc | Michael E. Daniels | Director, Chairman, President & CEO | Grant, award, or other acquisition of securities at price $ 131.43 per share. | 20 Jan 2026 | 12,125 | 122,757 (1%) | 0% | 131.4 | 1,593,589 | Common Stock |
| Minerals Tech Inc | Brett Argirakis | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 12,101 | 30,603 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Gamestop Corp (Class A) | Alain Attal | Director | Purchase of securities on an exchange or from another person at price $ 20.90 per share. | 20 Jan 2026 | 12,000 | 584,464 (0%) | 0% | 20.9 | 250,798 | Class A Common Stock |
| Outset Medical Inc | Leslie L. Trigg | Director, Chair and CEO | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 20 Jan 2026 | 11,794 | 107,823 | - | 5.1 | 60,385 | Common Stock |
| Minerals Tech Inc | D. J. Monagle | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 10,739 | 10,739 | - | - | Employee Stock Option (Right to Buy) | |
| Minerals Tech Inc | Brett Argirakis | Group President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 10,393 | 10,393 | - | - | Employee Stock Option (Right to Buy) | |
| Alx Oncology Holdings Inc | Alan B. Sandler | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 10,100 | 10,100 | - | - | Stock option (right to buy) | |
| Progressive | Susan Patricia Griffith | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.32 per share. | 20 Jan 2026 | 10,005 | 485,190 (0%) | 0% | 201.3 | 2,014,207 | Common |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 20 Jan 2026 | 10,000 | 147,486 (0%) | 0% | - | Class A Common Stock | ||
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | 20 Jan 2026 | 10,000 | 8,925 | - | - | Class B Common Stock | ||
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 10,000 | 18,925 | - | - | Class B Common Stock | |
| Cloudflare Inc (Class A) | Thomas Josef Seifert | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 10,000 | 80,341 | - | - | Employee Stock Option (right to buy) | |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 19.08 per share. | 20 Jan 2026 | 10,000 | 100,270 (0%) | 0% | 19.1 | 190,800 | Common Stock |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Sale of securities on an exchange or to another person at price $ 27.34 per share. | 20 Jan 2026 | 10,000 | 90,270 (0%) | 0% | 27.3 | 273,420 | Common Stock |
| Travere Therapeutics Inc | Elizabeth E. Reed | Chief Legal Officer and GC | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 10,000 | 30,000 | - | - | Employee stock option (right to buy) | |
| Grid Dynamics Holdings Inc (Class A) | Leonard Livschitz | Director, CHIEF EXECUTIVE OFFICER | Sale of securities on an exchange or to another person at price $ 9.00 per share. | 20 Jan 2026 | 10,000 | 3,124,343 | - | 9 | 90,000 | Common Stock |
| Olema Pharma Inc | Cyrus L. Harmon | Director | Sale of securities on an exchange or to another person at price $ 26.88 per share. | 20 Jan 2026 | 10,000 | 727,770 | - | 26.9 | 268,800 | Common Stock |
| Capital City Bank Grp Inc | William G. Smith | Director, CHAIRMAN, PRESIDENT & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 9,868 | 2,369,664 (14%) | 0% | 0 | Common Stock | |
| PPL | Wendy E. Stark | EVP & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.91 per share. | 20 Jan 2026 | 9,650 | 69,681 (0%) | 0% | 36.9 | 356,190 | Common Stock |
| PPL | Wendy E. Stark | EVP & CLO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 9,650 | 0 | - | - | Stock Unit (SIP) | |
| H.B. Fuller Co | Celeste Beeks Mastin | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 9,533 | 9,533 | - | - | Performance Stock Units | |
| Outset Medical Inc | John L. Brottem | General Counsel | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 20 Jan 2026 | 9,314 | 36,957 | - | 5.1 | 47,688 | Common Stock |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 30.34 per share. | 20 Jan 2026 | 9,067 | 91,617 | - | 30.3 | 275,114 | Class A Common Stock |
| Capital City Bank Grp Inc | William G. Smith | Director, CHAIRMAN, PRESIDENT & CEO, Ten Percent Owner | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,904 | 2,378,568 (14%) | 0% | 0 | Common Stock | |
| Capital City Bank Grp Inc | Thomas A. Barron | Director, TREASURER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,770 | 152,067 (0%) | 0% | 0 | Common Stock-Direct | |
| Citigroup | Andrew John Morton | Head of Markets | Payment of exercise price or tax liability using portion of securities received from the company at price $ 118.05 per share. | 20 Jan 2026 | 8,740 | 402,433 (0%) | 0% | 118.1 | 1,031,765 | Common Stock |
| Protagonist Therapeutics Inc | Asif Ali | Chief Financial Officer | Sale of securities on an exchange or to another person at price $ 82.48 per share. | 20 Jan 2026 | 8,588 | 78,077 (0%) | 0% | 82.5 | 708,338 | Common Stock |
| Minerals Tech Inc | Erik Aldag | SVP FINANCE AND TREASURY, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,557 | 21,616 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Neuphoria Therapeutics Inc | Peter Miles Davies | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,537 | 15,320 | - | - | Restricted Stock Units | |
| Neuphoria Therapeutics Inc | Jane Ryan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,537 | 15,550 | - | - | Restricted Stock Units | |
| Neuphoria Therapeutics Inc | David Wilson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,537 | 15,412 | - | - | Restricted Stock Units | |
| Apellis Pharma Inc | Cedric Francois | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 19.79 per share. | 20 Jan 2026 | 8,182 | 313,237 (0%) | 0% | 19.8 | 161,946 | Common Stock |
| First Internet Bancorp | Nicole S. Lorch | President & COO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 8,084 | 78,449 (0%) | 0% | 0 | Common Stock | |
| Atlassian Corp (Class A) | Michael Cannon-Brookes | Director, CEO, Co-Founder, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 118.19 per share. | 20 Jan 2026 | 7,665 | 375,585 (0%) | 0% | 118.2 | 905,916 | Class A Common Stock |
| Atlassian Corp (Class A) | Scott Farquhar | Director, Ten Percent Owner | Sale of securities on an exchange or to another person at price $ 118.19 per share. | 20 Jan 2026 | 7,665 | 375,585 (0%) | 0% | 118.2 | 905,916 | Class A Common Stock |
| Minerals Tech Inc | Erik Aldag | SVP FINANCE AND TREASURY, CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 7,349 | 7,349 | - | - | Employee Stock Option (Right to Buy) | |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 5.01 per share. | 20 Jan 2026 | 7,317 | 98,934 | - | 5.0 | 36,658 | Class A Common Stock |
| Hims & Hers Health Inc (Class A) | Oluyemi Okupe | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,317 | 149,313 | - | - | Stock Option (right to buy) | |
| Linde | Stephen F. Angel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,248 | 462,791 (0%) | 0% | 0 | Ordinary Shares | |
| Linde | Stephen F. Angel | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 7,248 | 102,579 | - | - | Deferred Stock Units | |
| Minerals Tech Inc | Timothy J. Jordan | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 7,030 | 18,730 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Progressive | John Peter Sauerland | VP and Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 6,776 | 12,830 | - | - | Restricted Stock Unit | |
| Progressive | John Peter Sauerland | VP and Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 6,776 | 229,800 (0%) | 0% | 0 | Common | |
| Innovative Industrial Properties Inc | Andy Bui | VP, CHIEF ACCOUNTING OFFICER | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 6,522 | 16,186 (0%) | 0% | - | Common Stock | |
| Progressive | Patrick K. Callahan | Personal Lines President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 6,270 | 11,818 | - | - | Restricted Stock Unit | |
| Progressive | Patrick K. Callahan | Personal Lines President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 6,270 | 21,461 (0%) | 0% | 0 | Common | |
| Teledyne Tech | Robert Mehrabian | Director, Executive Chairman | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 6,207 | 6,207 | - | - | Restricted Stock Units | |
| Essential Properties Realty Trust Inc | A Joseph Peil | Executive VP and CIO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.04 per share. | 20 Jan 2026 | 6,183 | 70,755 (0%) | 0% | 30.0 | 185,737 | Common Stock |
| PPL | John R. Crockett | President of a PPL Subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 6,090 | 0 | - | - | Stock Unit (SIP) | |
| PPL | John R. Crockett | President of a PPL Subsidiary | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.91 per share. | 20 Jan 2026 | 6,090 | 29,739 (0%) | 0% | 36.9 | 224,790 | Common Stock |
| Minerals Tech Inc | Timothy J. Jordan | Vice President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 6,038 | 6,038 | - | - | Employee Stock Option (Right to Buy) | |
| Leggett & Platt Inc | Karl G. Glassman | Director, President and CEO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 12.13 per share. | 20 Jan 2026 | 6,006 | 920,393 (0%) | 0% | 12.1 | 72,853 | Common Stock |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 6,000 | 12,000 | - | - | Stock Option | |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.95 per share. | 20 Jan 2026 | 6,000 | 43,037 (0%) | 0% | 4.0 | 23,700 | Common Stock |
| Arcellx Inc | David Charles Lubner | Director | Sale of securities on an exchange or to another person at price $ 75.00 per share. | 20 Jan 2026 | 6,000 | 21,659 | - | 75 | 450,000 | Common Stock |
| Arcellx Inc | David Charles Lubner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 6,000 | 59,405 | - | - | Stock Option (right to buy) | |
| Arcellx Inc | David Charles Lubner | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.28 per share. | 20 Jan 2026 | 6,000 | 27,659 | - | 6.3 | 37,680 | Common Stock |
| Equitable Holdings Inc | Mark Pearson | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.77 per share. | 20 Jan 2026 | 5,862 | 652,945 (0%) | 0% | 46.8 | 274,166 | Common Stock |
| PPL | Angela K. Gosman | EVP and CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.91 per share. | 20 Jan 2026 | 5,722 | 34,340 (0%) | 0% | 36.9 | 211,221 | Common Stock |
| PPL | Angela K. Gosman | EVP and CHRO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,722 | 0 | - | - | Stock Unit (SIP) | |
| ZipRecruiter Inc (Class A) | Boris F. Shimanovsky | EVP, Chief Technology Officer | Sale of securities on an exchange or to another person at price $ 2.61 per share. | 20 Jan 2026 | 5,650 | 336,287 | - | 2.6 | 14,739 | Class A Common Stock |
| Progressive | John Jo Murphy | Claims President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,423 | 48,928 (0%) | 0% | 0 | Common | |
| Progressive | John Jo Murphy | Claims President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,423 | 10,532 | - | - | Restricted Stock Unit | |
| Outset Medical Inc | Marc Nash | EVP Operations R&D & Service | Sale of securities on an exchange or to another person at price $ 5.12 per share. | 20 Jan 2026 | 5,375 | 42,785 | - | 5.1 | 27,520 | Common Stock |
| PPL | David J. Bonenberger | EVP & COO-Utilities | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,197 | 0 | - | - | Stock Unit (SIP) | |
| PPL | David J. Bonenberger | EVP & COO-Utilities | Exercise or conversion of derivative security received from the company (such as an option) at price $ 36.92 per share. | 20 Jan 2026 | 5,197 | 50,900 (0%) | 0% | 36.9 | 191,848 | Common Stock |
| Essential Properties Realty Trust Inc | Robert Max Jenkins | Executive VP and COO | Payment of exercise price or tax liability using portion of securities received from the company at price $ 30.09 per share. | 20 Jan 2026 | 5,152 | 30,400 (0%) | 0% | 30.1 | 155,024 | Common Stock |
| Progressive | Lori A. Niederst | CRM President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,111 | 9,669 | - | - | Restricted Stock Unit | |
| Progressive | Lori A. Niederst | CRM President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,111 | 44,152 (0%) | 0% | 0 | Common | |
| Progressive | Karen B. Bailo | Commercial Lines President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,062 | 37,408 (0%) | 0% | 0 | Common | |
| Progressive | Karen B. Bailo | Commercial Lines President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,062 | 10,997 | - | - | Restricted Stock Unit | |
| Progressive | Steven A. Broz | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,008 | 31,362 (0%) | 0% | 0 | Common | |
| Progressive | Steven A. Broz | Chief Information Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,008 | 9,572 | - | - | Restricted Stock Unit | |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.00 per share. | 20 Jan 2026 | 5,000 | 39,592 (0%) | 0% | 7.0 | 35,025 | Common Stock |
| Perma-Fix Environmental Services Inc | Richard Grondin | EVP of Hanford & Int. Waste Op | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,000 | 5,000 | - | - | Stock Option | |
| Gilead Sciences | Jeffrey A. Bluestone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 67.45 per share. | 20 Jan 2026 | 5,000 | 13,920 (0%) | 0% | 67.5 | 337,250 | Common Stock |
| Gilead Sciences | Jeffrey A. Bluestone | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,000 | 4,665 | - | - | Non-qualified Stock Option (Right to Buy) | |
| Gilead Sciences | Jeffrey A. Bluestone | Director | Sale of securities on an exchange or to another person at price $ 123.50 per share. | 20 Jan 2026 | 5,000 | 8,920 (0%) | 0% | 123.5 | 617,500 | Common Stock |
| Daktronics Inc | Bradley T. Wiemann | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.11 per share. | 20 Jan 2026 | 5,000 | 126,611 (0%) | 0% | 4.1 | 20,550 | Common Stock |
| Daktronics Inc | Bradley T. Wiemann | President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 5,000 | 0 | - | - | Incentive Stock Options | |
| Gevo Inc | Andrew L. Shafer | Chief Cust Mkt & Brnd Officer | Sale of securities on an exchange or to another person at price $ 1.99 per share. | 20 Jan 2026 | 5,000 | 270,823 (1%) | 0% | 2.0 | 9,940 | Common Stock |
| Kymera Therapeutics Inc | Pamela Esposito | Director | Sale of securities on an exchange or to another person at price $ 67.99 per share. | 20 Jan 2026 | 4,900 | 200 | - | 68.0 | 333,145 | Common Stock |
| Progressive | Andrew J. Quigg | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 4,756 | 42,734 (0%) | 0% | 0 | Common | |
| Progressive | Andrew J. Quigg | Chief Strategy Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 4,756 | 9,225 | - | - | Restricted Stock Unit | |
| First Internet Bancorp | Kenneth J. Lovik | Executive Vice President & CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 4,620 | 52,849 (0%) | 0% | 0 | Common Stock | |
| Minerals Tech Inc | Michael A. Cipolla | VICE PRESIDENT | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jan 2026 | 4,618 | 12,632 | - | - | Deferred Restricted Stock Units (DRSUs) | |
| Progressive | Jonathan S. Bauer | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 4,602 | 9,175 | - | - | Restricted Stock Unit | |
| Progressive | Jonathan S. Bauer | Chief Investment Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jan 2026 | 4,602 | 30,849 (0%) | 0% | 0 | Common |
This section tracks all disclosures required by the U.S. Securities and Exchange Commission (SEC) under the Securities Exchange Act of 1934, particularly those related to Section 16 and Rule 10b-5, which govern insider trading activities in the U.S. market. These disclosures are made by corporate insiders, including executives, officers, directors, significant employees, and large shareholders, who are buying and selling stock in their own companies. You can search and filter within these results. You can also sort the information by clicking on the column headers.